COMMUNIQUÉS West-GlobeNewswire

MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Top Pharma Partner
19/07/2018
Exclusive global license agreement with Novartis on MOR106 MOR106, a monoclonal antibody directed against IL-17C, will be developed further in atopic dermatitis (AtD) and potentially other indications Up-front payment [...]
Basilea reports receipt of milestone payment based on first Cresemba® approval in Latin America
19/07/2018
Basel, Switzerland, July 19, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has received a CHF 2 million milestone payment from its partner Grupo Biotoscana S.L. ("GBT"), based on the first [...]
Novartis demonstrates commitment to lead immuno-dermatology by in-licensing IL-17C compound for atopic dermatitis
19/07/2018
Novartis enters an exclusive license agreement with Galapagos and MorphoSys for an investigational biologic compound, MOR106, a novel antibody directed against IL-17C IL-17C is believed to contribute significantly to [...]
Evolus, Inc. Announces Pricing of Public Offering of Common Stock
19/07/2018
IRVINE, Calif., July 18, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (Nasdaq:EOLS) (“Evolus”) announced today the pricing of its public offering of 4,000,000 shares of common stock at a public offering price of $20.00 per [...]
Establishment Labs Announces Pricing of Initial Public Offering
19/07/2018
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies, today announced the pricing [...]
Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
19/07/2018
STAMFORD, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
AC Immune Announces Price of USD 11.75 for Offerings and Issuance of up to 10 Million Common Shares
19/07/2018
Lausanne, Switzerland, July 19, 2018 - AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company focused on neurodegenerative diseases, today announced the price per common share of USD 11.75 [...]
Vigil Health Solutions Announces Normal Course Issuer Bid
19/07/2018
VICTORIA, British Columbia, July 18, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil” or the “Company”) (TSX-VEN:VGL) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice of [...]
Emergent BioSolutions to Release Second Quarter 2018 Financial Results and Conduct a Conference Call on August 2, 2018
18/07/2018
GAITHERSBURG, Md., July 18, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, August 2, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the [...]
LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018
18/07/2018
BURLINGTON, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2018 financial results on Thursday, July 26, 2018, after the market [...]
Resonant Engages LHA for Strategic Investor Relations Services
18/07/2018
GOLETA, Calif., July 18, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ:RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for wireless devices, today announced [...]
Cancer Genetics Closes $2.625 million Convertible Note Financing
18/07/2018
RUTHERFORD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the closing of a $ [...]
BioPorto submits FDA application for The NGAL Test™
18/07/2018
July 18, 2018 Announcement no. 13 BioPorto A/S (“BioPorto”) announces today that the company has submitted an application to the US Food and Drug Administration, (“FDA”), for regulatory clearance of The NGAL Test™ for [...]
Amedisys Announces Second Quarter Earnings Release and Conference Call Date
18/07/2018
BATON ROUGE, La., July 18, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), announced today that it will report results for the second quarter ended June 30, 2018 after the market closes on July 31, 2018. The [...]
Health Care Administrators Association (HCAA) Appoints 2018-2019 Board of Directors
18/07/2018
Joanie Verinder to lead self-funding industry initiatives for the association as the new president MINNEAPOLIS, July 18, 2018 (GLOBE NEWSWIRE) -- The Health Care Administrators Association (HCAA) , a leader in education [...]
Tabula Rasa HealthCare Appoints Two New Members to the Board of Directors
18/07/2018
Adds world class healthcare leadership and financial strength MOORESTOWN, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc . (TRHC) (NASDAQ:TRHC), a healthcare technology company advancing the field [...]
ERPSI Wins $6.6M Contract to Provide TSA with Application Production Support
18/07/2018
ARLINGTON, Va., July 18, 2018 (GLOBE NEWSWIRE) -- The US Department of Homeland Security (DHS) Transportation Security Administration’s (TSA) Applications Development Division (ADD) has awarded Enterprise Resource [...]
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast
18/07/2018
PHOENIX, July 18, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTC PINK:BIEI) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast. Premier Biomedical currently [...]
Information concerning the total number of voting rights and shares
18/07/2018
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

Pages